WO2004106329A3 - Novel antiinfective compounds and their pharmaceutical compositions - Google Patents

Novel antiinfective compounds and their pharmaceutical compositions

Info

Publication number
WO2004106329A3
WO2004106329A3 PCT/IB2004/001811 IB2004001811W WO2004106329A3 WO 2004106329 A3 WO2004106329 A3 WO 2004106329A3 IB 2004001811 W IB2004001811 W IB 2004001811W WO 2004106329 A3 WO2004106329 A3 WO 2004106329A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical compositions
novel
antiinfective compounds
compounds
novel antiinfective
Prior art date
Application number
PCT/IB2004/001811
Other languages
French (fr)
Other versions
WO2004106329A2 (en
Inventor
Takhi Mohamed
Jagattaran Das
Selvakumar Natesan
Sanjay Trehan
Javed Iqbal
Sitaram Kumar Magadi
Original Assignee
Reddys Lab Ltd Dr
Takhi Mohamed
Jagattaran Das
Selvakumar Natesan
Sanjay Trehan
Javed Iqbal
Sitaram Kumar Magadi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Ltd Dr, Takhi Mohamed, Jagattaran Das, Selvakumar Natesan, Sanjay Trehan, Javed Iqbal, Sitaram Kumar Magadi filed Critical Reddys Lab Ltd Dr
Publication of WO2004106329A2 publication Critical patent/WO2004106329A2/en
Publication of WO2004106329A3 publication Critical patent/WO2004106329A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Abstract

The present invention provides novel triazole compounds of formula (I), their pharmaceutically acceptable salts and their pharmaceutical compositions, where all symbols are as defined in the specification
PCT/IB2004/001811 2003-06-03 2004-06-03 Novel antiinfective compounds and their pharmaceutical compositions WO2004106329A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN448MA2003 2003-06-03
IN448/MAS/2003 2003-06-03

Publications (2)

Publication Number Publication Date
WO2004106329A2 WO2004106329A2 (en) 2004-12-09
WO2004106329A3 true WO2004106329A3 (en) 2005-01-13

Family

ID=33485473

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2004/001811 WO2004106329A2 (en) 2003-06-03 2004-06-03 Novel antiinfective compounds and their pharmaceutical compositions

Country Status (1)

Country Link
WO (1) WO2004106329A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7696352B2 (en) 2004-06-18 2010-04-13 Millennium Pharmaceuticals, Inc. Factor Xa inhibitors
AU2005257999B2 (en) 2004-06-18 2011-12-08 Millennium Pharmaceuticals, Inc. Factor Xa inhibitors
US20070060658A1 (en) * 2005-08-31 2007-03-15 Diaz David D Stabilization of organogels and hydrogels by azide-alkyne [3+2] cycloaddition
US7763608B2 (en) 2006-05-05 2010-07-27 Millennium Pharmaceuticals, Inc. Factor Xa inhibitors
US8742120B2 (en) 2009-12-17 2014-06-03 Millennium Pharmaceuticals, Inc. Methods of preparing factor xa inhibitors and salts thereof
US8530501B2 (en) 2009-12-17 2013-09-10 Millennium Pharmaceuticals, Inc. Salts and crystalline forms of a factor Xa inhibitor
ITMI20131180A1 (en) * 2013-07-15 2015-01-16 Fond Istituto Italiano Di Tecnologia O-ALCHIL TRIAZOLYL CARBAMMATES AS INHIBITORS OF HYDROLASIS OF AMIDIDES OF FATTY ACIDS (FAAH)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0199262A2 (en) * 1985-04-18 1986-10-29 Ciba-Geigy Ag Fluorinated benzyl triazole compounds
US6110936A (en) * 1996-05-11 2000-08-29 Zeneca Limited 3-phenyl-furan-(5H)-2-one and dihydrofuran-2-one derivatives as antibacterial agents
WO2003059894A1 (en) * 2002-01-18 2003-07-24 Dr.Reddy's Laboratories Ltd. Novel antibacterial compounds:process for their preparation and pharmaceutical compositions containing them.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0199262A2 (en) * 1985-04-18 1986-10-29 Ciba-Geigy Ag Fluorinated benzyl triazole compounds
US6110936A (en) * 1996-05-11 2000-08-29 Zeneca Limited 3-phenyl-furan-(5H)-2-one and dihydrofuran-2-one derivatives as antibacterial agents
US20030166684A1 (en) * 1996-05-11 2003-09-04 Gravestock Michael Barry 3-phenyl-furan-(5H)-2-one and dihydrofuran-2-one derivatives as antibacterial agents
WO2003059894A1 (en) * 2002-01-18 2003-07-24 Dr.Reddy's Laboratories Ltd. Novel antibacterial compounds:process for their preparation and pharmaceutical compositions containing them.

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BOCHIS R J ET AL: "BENZYLATED 1,2,3-TRIAZOLES AS ANTICOCCIDIOSTATS", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 34, no. 9, 1 September 1991 (1991-09-01), pages 2843 - 2852, XP000567810, ISSN: 0022-2623 *
BRICKNER S J: "OXAZOLIDINONE ANTIBACTERIAL AGENTS", CURRENT PHARMACEUTICAL DESIGN, BENTHAM SCIENCE PUBLISHERS, SCHIPHOL, NL, vol. 2, 1996, pages 175 - 194, XP001007528, ISSN: 1381-6128 *
GRAVESTOCK M B ET AL: "New classes of antibacterial oxazolidinones with C-5, methylene O-Linked heterocyclic side chains", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 13, 1 December 2003 (2003-12-01), pages 4179 - 4186, XP002275942, ISSN: 0960-894X *
HABEEB, A. G. ET AL.: "Design and Synthesis of Celecobix and Rofecobix Analogues as Selective Cyclooxygenase-2 (COX-2) Inhibitors", J. MED. CHEM., vol. 44, no. 18, 2001, pages 3039 - 3042, XP002304944 *

Also Published As

Publication number Publication date
WO2004106329A2 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
WO2007120647A3 (en) Compositions useful as inhibitors of voltage-gated sodium channels
GB0114286D0 (en) Nucleoside Derivatives
AU2003244632A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
WO2006011050A3 (en) Pyridine derivatives
WO2004074244A3 (en) Pyrimidine compounds
WO2005082892A3 (en) Triazole compounds as antibacterial agents and pharmaceutical compositions containing them
WO2003037860A3 (en) Purine analogs having hsp90-inhibiting activity
GB0321607D0 (en) Manufacture of pharmaceutical compositions
WO2005049581A8 (en) Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors
WO2003059898A3 (en) Eponemycin and epoxomicin analogs and uses thereof
UA83091C2 (en) Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors
WO2005051302A3 (en) Bicyclic inhibitors of mek and methods of use thereof
AU2003227741A1 (en) Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
WO2004014322A3 (en) Immunomodulatory compositions, methods of making, and methods of use thereof
AU2003244649A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
IL173807A0 (en) Amphiphilic antioxidant compounds, mitoquinone derivatives and pharmaceutical compositions containing the same
EP1631239A4 (en) Pharmaceutical compositions comprising active vitamin d compounds
WO2006116733A3 (en) Protein kinase inhibitors
WO2002102793A3 (en) Quinazolinediones as antibacterial agents
IL174507A0 (en) Pharmaceutical compositions comprising malonamide derivatives for decreasing sebum production
WO2004093800A3 (en) Thyronamine derivatives and analogs and methods of use thereof
TW200604197A (en) New compounds
AU2003292263A1 (en) Use of substituted 2-phenylbenzimidazoles as medicaments
WO2005009348A3 (en) Substituted purine derivatives
WO2004106329A3 (en) Novel antiinfective compounds and their pharmaceutical compositions

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
122 Ep: pct application non-entry in european phase